发明名称 SUSTAINED RELEASE HETERODISPERSE HYDROGEL SYSTEMS AMORPHOUS DRUGS
摘要 PURPOSE: Sustained release oral solid dosage is provided which comprising agglomerated particles of a therapeutically active medicament in amorphous form, a gelling agent, an ionizable gel strength enhancing agent and an inert diluent, as well as processes for preparing and using the same are disclosed. CONSTITUTION: A sustained release oral solid dosage form comprising an effective amount of a medicament in amorphous form having a solubility of less than about 10 g/l to render a therapeutic effect; a sustained release excipient comprising a gelling agent, an inert pharmaceutical diluent, and an effective amount of a pharmaceutically acceptable ionizable gel strength enhancer which increases the gel strength of the formulation and thereby desirably controls the release of medicament from the gel to provide a sustained release of the medicament, when the dosage form is exposed to an environmental fluid. The ratio of medicament to gelling agent is preferably from about 1:3 to about 1:8. The sustained release solid dosage form preferably provides a therapeutically effective blood level of the medicament for at least about 12 hours or more, and in certain preferred embodiments, for up to about 24 hours. The active medicament is rendered amorphous by dispersion into a mixture comprising, a solid solubilizing agent.
申请公布号 KR20000005554(A) 申请公布日期 2000.01.25
申请号 KR19987008354 申请日期 1998.10.17
申请人 EDWARD MENDEL CO., INC. 发明人 BAICHWAL, ANAND, R.
分类号 A61K47/42;A61K9/20;A61K9/22;A61K9/26;A61K9/28;A61K9/30;A61K47/36;C08J3/075;C08J3/20;(IPC1-7):C08J3/075 主分类号 A61K47/42
代理机构 代理人
主权项
地址